Document is current

Any future updates will be listed below

Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience

Crossref DOI link: https://doi.org/10.1007/s00280-015-2910-9

Published Online: 2016-03-31

Published Print: 2016-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark